23155049|t|Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.
23155049|a|Accumulation of beta-amyloid (Abeta) deposits is a primary pathological feature of Alzheimer disease that is correlated with neurotoxicity and cognitive decline. The role of glycogen synthase kinase-3 (GSK-3) in Alzheimer disease pathogenesis has been debated. To study the role of GSK-3 in Abeta pathology, we used 5XFAD mice co-expressing mutated amyloid precursor protein and presenilin-1 that develop massive cerebral Abeta loads. Both GSK-3 isozymes (alpha/beta) were hyperactive in this model. Nasal treatment of 5XFAD mice with a novel substrate competitive GSK-3 inhibitor, L803-mts, reduced Abeta deposits and ameliorated cognitive deficits. Analyses of 5XFAD hemi-brain samples indicated that L803-mts restored the activity of mammalian target of rapamycin (mTOR) and inhibited autophagy. Lysosomal acidification was impaired in the 5XFAD brains as indicated by reduced cathepsin D activity and decreased N-glycoyslation of the vacuolar ATPase subunit V0a1, a modification required for lysosomal acidification. Treatment with L803-mts restored lysosomal acidification in 5XFAD brains. Studies in SH-SY5Y cells confirmed that GSK-3alpha and GSK-3beta impair lysosomal acidification and that treatment with L803-mts enhanced the acidic lysosomal pool as demonstrated in LysoTracker Red-stained cells. Furthermore, L803-mts restored impaired lysosomal acidification caused by dysfunctional presenilin-1. We provide evidence that mTOR is a target activated by GSK-3 but inhibited by impaired lysosomal acidification and elevation in amyloid precursor protein/Abeta loads. Taken together, our data indicate that GSK-3 is a player in Abeta pathology. Inhibition of GSK-3 restores lysosomal acidification that in turn enables clearance of Abeta burdens and reactivation of mTOR. These changes facilitate amelioration in cognitive function.
23155049	14	40	glycogen synthase kinase-3	Gene	56637
23155049	53	65	beta-amyloid	Disease	MESH:C000718787
23155049	117	146	mammalian target of rapamycin	Gene	56717
23155049	163	180	Alzheimer disease	Disease	MESH:D000544
23155049	181	186	mouse	Species	10090
23155049	254	259	Abeta	Gene	11820
23155049	273	274	a	Gene	11820
23155049	307	324	Alzheimer disease	Disease	MESH:D000544
23155049	349	362	neurotoxicity	Disease	MESH:D020258
23155049	367	384	cognitive decline	Disease	MESH:D003072
23155049	398	424	glycogen synthase kinase-3	Gene	56637
23155049	426	431	GSK-3	Gene	56637
23155049	436	453	Alzheimer disease	Disease	MESH:D000544
23155049	506	511	GSK-3	Gene	56637
23155049	515	520	Abeta	Gene	11820
23155049	540	545	5XFAD	CellLine	CVCL:5U93
23155049	546	550	mice	Species	10090
23155049	573	598	amyloid precursor protein	Gene	11820
23155049	603	615	presenilin-1	Gene	19164
23155049	646	651	Abeta	Gene	11820
23155049	680	690	alpha/beta	Gene	11820
23155049	743	748	5XFAD	Disease	
23155049	749	753	mice	Species	10090
23155049	759	760	a	Gene	11820
23155049	789	794	GSK-3	Gene	56637
23155049	806	814	L803-mts	Chemical	MESH:C509073
23155049	824	829	Abeta	Gene	11820
23155049	855	873	cognitive deficits	Disease	MESH:D003072
23155049	887	892	5XFAD	Disease	
23155049	927	935	L803-mts	Chemical	MESH:C509073
23155049	961	990	mammalian target of rapamycin	Gene	56717
23155049	992	996	mTOR	Gene	56717
23155049	1067	1072	5XFAD	Disease	
23155049	1104	1115	cathepsin D	Gene	1509
23155049	1192	1193	a	Gene	11820
23155049	1260	1268	L803-mts	Chemical	MESH:C509073
23155049	1305	1310	5XFAD	Disease	
23155049	1330	1337	SH-SY5Y	CellLine	CVCL:0019
23155049	1359	1369	GSK-3alpha	Gene	2931
23155049	1374	1383	GSK-3beta	Gene	2932
23155049	1439	1447	L803-mts	Chemical	MESH:C509073
23155049	1502	1517	LysoTracker Red	Chemical	-
23155049	1546	1554	L803-mts	Chemical	MESH:C509073
23155049	1621	1633	presenilin-1	Gene	19164
23155049	1660	1664	mTOR	Gene	56717
23155049	1668	1669	a	Gene	11820
23155049	1690	1695	GSK-3	Gene	56637
23155049	1763	1788	amyloid precursor protein	Gene	11820
23155049	1789	1794	Abeta	Gene	11820
23155049	1841	1846	GSK-3	Gene	56637
23155049	1850	1851	a	Gene	11820
23155049	1862	1867	Abeta	Gene	11820
23155049	1893	1898	GSK-3	Gene	56637
23155049	1966	1971	Abeta	Gene	11820
23155049	2000	2004	mTOR	Gene	56717
23155049	Association	MESH:D003072	11820
23155049	Association	11820	56637
23155049	Association	MESH:D000544	11820
23155049	Negative_Correlation	MESH:C509073	56637
23155049	Negative_Correlation	MESH:C509073	11820
23155049	Association	MESH:D020258	11820
23155049	Association	MESH:C000718787	56637
23155049	Negative_Correlation	MESH:C509073	MESH:D003072
23155049	Association	11820	19164
23155049	Positive_Correlation	56637	56717
23155049	Positive_Correlation	MESH:C509073	56717
23155049	Association	MESH:D000544	56637

